National Human Genome Research Institute; Notice of Closed Meetings, 70974-70975 [06-9576]
Download as PDF
70974
Federal Register / Vol. 71, No. 235 / Thursday, December 7, 2006 / Notices
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The purpose of this
meeting is to evaluate proposals for
support through the RAID program by
making available to the research
community, on a competitive basis, NCI
new agent development contract
resources for the preclinical
development of drugs and biologics.
The outcome of the evaluation will be
a decision whether NCI should support
the request and make available contract
resources for support through the RAID
program to the research community,
NCI new agent development for the
preclinical development of drugs and
biologics. The research proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the
proposed research projects, the
disclosure of which would constitute a
clearly unwarranted invasion of
personal privacy.
sroberts on PROD1PC70 with NOTICES
Name of Committee: National Cancer
Institute Special Emphasis Panel Rapid
Access to Intervention Development.
Date: December 20, 2006.
Time: 8:30 a.m.–5 p.m.
Agenda: To evaluate Rapid Access to
Intervention Development Portfolio.
Place: National Institutes of Health, 6130
Executive Boulevard, Rm. 319, Rockville, MD
20852.
Contact Person: Phyllis G. Bryant,
Executive Secretary, Program Analyst,
Developmental Therapeutics Program,
National Cancer Institute, NIH, 6130
Executive Boulevard, Rm. 8022, Bethesda,
MD 20892, 301 435–9137.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: November 30, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–9577 Filed 12–6–06; 8:45 am]
BILLING CODE 4140–01–M
VerDate Aug<31>2005
17:29 Dec 06, 2006
Jkt 211001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
National Institutes of Health
Dated: December 1, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–9573 Filed 12–6–06; 8:45 am]
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Demonstration and Education Research
Grants.
Date: December 15, 2006.
Time: 9 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Patricia A. Haggerty, PhD,
Scientific Review Administrator, National
Heart, Lung, and Blood Institute/NIH,
Clinical Studies & Training Studies Rev.
Grp., Division of Extramural Affairs/Section
Chief, 6701 Rockledge Drive, Room 7194,
Bethesda, MD 20892, 301/435–0288,
haggertp@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Coronary Intervention Trial.
Date: December 19, 2006.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: William J. Johnson, PhD,
Scientific Review Administrator, Review
Branch, Division of Extramural Research
Activities, NIH/NHLBI, 6701 Rockledge
Drive, Bethesda, MD 20892–7924, 301–435–
0317, johnsonw@nhlbi.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Inherited
Disease Research Access Committee Group
A.
Date: January 5, 2007.
Time: 8:30 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Jerry Roberts, PhD,
Scientific Review Administrator, Scientific
Review Branch, National Institutes of Health,
Building 38A, Bethesda, MD 20892, 301 402–
0838.
Name of Committee: Center for Inherited
Disease Research Access Committee Group B.
Date: January 5, 2007.
Time: 3:15 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Rudy Pozzatti, PhD,
Scientific Review Administrator, Scientific
Review Branch, National Human Genome
Research Institute, 5635 Fishers Lane, Suite
4076, MSC 9306, Bethesda, MD 20852, (301)
402–0838, pozzattr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
E:\FR\FM\07DEN1.SGM
07DEN1
Federal Register / Vol. 71, No. 235 / Thursday, December 7, 2006 / Notices
Dated: November 30, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–9576 Filed 12–6–06; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Meeting
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Board of Scientific Counselors, NIDA.
The meeting will be closed to the public
as indicated below in accordance with
the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute on Drug Abuse,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
sroberts on PROD1PC70 with NOTICES
Name of Committee: Board of Scientific
Counselors, NIDA.
Date: January 11, 2007.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: Intramural Research Program,
National Institute on Drug Abuse, NIH, Johns
Hopkins Bayview Campus, Bldg. C, 2nd
Floor Auditorium, Baltimore, MD 21224.
Contact Person: Stephen J. Heishman, PhD,
Research Psychologist, Clinical
Pharmacology Branch, Intramural Research
Program, National Institute on Drug Abuse,
National Institutes of Health, DHHS, 5500
Nathan Shock Drive, Baltimore, MD 21224,
(410) 550–1547.
(Catalogue of Federal Domestic Assistance
Program No. 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: December 1, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–9572 Filed 12–6–06; 8:45 am]
BILLING CODE 4140–01–M
VerDate Aug<31>2005
17:29 Dec 06, 2006
Jkt 211001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Advisory Mental Health
Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Mental Health Council.
Date: January 11–12, 2007.
Closed: January 11, 2007, 10 a.m. to 4:30
p.m.
Agenda: To review and evaluate grant
applications and the activities of the NIMH
Intramural Research Programs.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Conference Room C/D/E,
Rockville, MD 20852.
Open: January 12, 2007, 8:30 a.m. to 1 p.m.
Agenda: Presentation of NIMH Director’s
Report and discussion on NIMH program and
policy issues.
Place: National Institutes of Health,
Building 31C, 31 Center Drive, 6th Floor,
Conference Room 6, Bethesda, MD 20892.
Contact Person: Jane A. Steinberg, PhD,
Director, Division of Extramural Activities,
National Institute of Mental Health, NIH,
Neuroscience Center, 6001 Executive Blvd.,
Room 6154, MSC 9609, Bethesda, MD 20892–
9609, 301–443–5047.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
70975
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when ap
the business or professional affiliation of the
interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.nimh.nih.gov/council/advis.cfm, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.242, Mental Health Research
Grants; 93.281, Scientist Development
Award, Scientists Development Award for
Clinicians, and Research Scientists Award;
93.282. Mental Health National Research
Service Awards for Research Training,
National Institutes of Health, HHS)
Dated: December 1, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–9574 Filed 12–6–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclose of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Deafness and Other Communication
Disorders Special Emphasis Panel, P30 Grant
Review.
E:\FR\FM\07DEN1.SGM
07DEN1
Agencies
[Federal Register Volume 71, Number 235 (Thursday, December 7, 2006)]
[Notices]
[Pages 70974-70975]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-9576]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Human Genome Research Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Inherited Disease Research Access
Committee Group A.
Date: January 5, 2007.
Time: 8:30 a.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road, NW., Washington, DC 20015.
Contact Person: Jerry Roberts, PhD, Scientific Review
Administrator, Scientific Review Branch, National Institutes of
Health, Building 38A, Bethesda, MD 20892, 301 402-0838.
Name of Committee: Center for Inherited Disease Research Access
Committee Group B.
Date: January 5, 2007.
Time: 3:15 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road, NW., Washington, DC 20015.
Contact Person: Rudy Pozzatti, PhD, Scientific Review
Administrator, Scientific Review Branch, National Human Genome
Research Institute, 5635 Fishers Lane, Suite 4076, MSC 9306,
Bethesda, MD 20852, (301) 402-0838, pozzattr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human
Genome Research, National Institutes of Health, HHS)
[[Page 70975]]
Dated: November 30, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-9576 Filed 12-6-06; 8:45 am]
BILLING CODE 4140-01-M